BioNano Genomics WT EXP 082123 BNGOW

$ 0.0 -23.4%

Quarterly report 2024-Q3
added 11-14-2024

BioNano Genomics WT EXP 082123 Balance Sheet 2011-2024 | BNGOW

Annual Balance Sheet BioNano Genomics WT EXP 082123

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-12.2 M	788 K	-19.5 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt	3.58 M	3.62 M	3.64 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.16 M	2.26 M	1.47 M	-	20.1 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	100 M	35.9 M	21.8 M	8.94 M	26.4 M	4.52 M	-	-	-	-	-	-	-
Total Liabilities	118 M	58.1 M	40 M	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	783 K	871 K	684 K	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-581 M	-349 M	-216 M	-	-	-	-	-	-	-	-	-	-
Total Assets	214 M	308 M	377 M	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	17.9 M	5.09 M	24.6 M	38.4 M	17.3 M	16.5 M	-	-	-	-	-	-	-
Book Value	96.2 M	249 M	337 M	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	96.2 M	249 M	337 M	35.1 M	3.61 M	10.1 M	-50.2 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet BioNano Genomics WT EXP 082123

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	3.55 M	3.56 M	3.58 M	3.58 M	3.6 M	3.6 M	3.61 M	3.62 M	3.63 M	-	3.64 M	3.64 M	-	-	14.9 M	16.3 M	16.3 M	16.3 M	16.3 M	-	-	-	18.4 M	9.03 M	9.03 M	9.03 M	9.03 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	38.5 M	49 M	75.2 M	118 M	62.9 M	56.6 M	60.7 M	58.1 M	42 M	-	37 M	40 M	18.1 M	10.9 M	22.1 M	25.4 M	25.4 M	25.4 M	25.4 M	26.6 M	26.6 M	26.6 M	26.6 M	14.7 M	14.7 M	14.7 M	14.7 M	17.4 M	17.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	1.2 M	1.15 M	1.04 M	783 K	811 K	978 K	1.13 M	871 K	976 K	-	1.11 M	684 K	411 K	445 K	301 K	416 K	412 K	416 K	416 K	357 K	418 K	358 K	214 K	271 K	336 K	271 K	271 K	212 K	212 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-673 M	-629 M	-613 M	-581 M	-537 M	-425 M	-386 M	-349 M	-310 M	-	-246 M	-216 M	-193 M	-172 M	-154 M	-144 M	-144 M	-144 M	-144 M	-103 M	-103 M	-103 M	-103 M	-72.8 M	-72.8 M	-72.8 M	-72.8 M	-54.3 M	-54.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	87.4 M	129 M	158 M	214 M	182 M	271 M	292 M	308 M	324 M	-	348 M	377 M	360 M	357 M	385 M	60.4 M	60.5 M	60.5 M	60.5 M	30.2 M	30.2 M	30.2 M	30.2 M	24.8 M	24.8 M	24.8 M	24.8 M	10.1 M	10.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	8.79 M	10.4 M	15.8 M	17.9 M	34.6 M	14.9 M	4.1 M	5.09 M	28.2 M	27.2 M	24 M	24.6 M	141 M	333 M	362 M	38.4 M	38.4 M	38.4 M	38.4 M	17.3 M	17.3 M	17.3 M	17.3 M	16.5 M	16.5 M	16.5 M	16.5 M	1.02 M	1.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	48.9 M	80.3 M	82.8 M	96.2 M	119 M	215 M	231 M	249 M	282 M	-	311 M	337 M	342 M	346 M	363 M	35.1 M	35.1 M	35.1 M	35.1 M	3.61 M	3.61 M	3.61 M	3.61 M	10.1 M	10.1 M	10.1 M	10.1 M	-7.22 M	-7.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	48.9 M	80.3 M	82.8 M	96.2 M	119 M	215 M	231 M	249 M	282 M	285 M	311 M	337 M	342 M	346 M	363 M	35.1 M	35.1 M	35.1 M	35.1 M	3.61 M	3.61 M	3.61 M	3.61 M	10.1 M	10.1 M	10.1 M	10.1 M	-50.2 M	-50.2 M	-	-	-27.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency